SE454518B - Forfarande for odling av diploida celler i nervaro av cellulosafibrer - Google Patents
Forfarande for odling av diploida celler i nervaro av cellulosafibrerInfo
- Publication number
- SE454518B SE454518B SE8402742A SE8402742A SE454518B SE 454518 B SE454518 B SE 454518B SE 8402742 A SE8402742 A SE 8402742A SE 8402742 A SE8402742 A SE 8402742A SE 454518 B SE454518 B SE 454518B
- Authority
- SE
- Sweden
- Prior art keywords
- cells
- cellulose
- fibers
- meq
- cell
- Prior art date
Links
- 239000000835 fiber Substances 0.000 title claims description 63
- 238000000034 method Methods 0.000 title claims description 16
- 238000012258 culturing Methods 0.000 title claims description 5
- 210000004027 cell Anatomy 0.000 claims description 105
- 229920002678 cellulose Polymers 0.000 claims description 43
- 239000001913 cellulose Substances 0.000 claims description 43
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical compound [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims description 19
- 210000002950 fibroblast Anatomy 0.000 claims description 18
- 230000012010 growth Effects 0.000 claims description 12
- 229920003043 Cellulose fiber Polymers 0.000 claims description 11
- 241000700605 Viruses Species 0.000 claims description 10
- 238000005342 ion exchange Methods 0.000 claims description 9
- 229960005486 vaccine Drugs 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 238000005349 anion exchange Methods 0.000 claims description 5
- -1 diethyl- (2-hydroxypropyl) -aminoethyl Chemical group 0.000 claims description 5
- 210000001840 diploid cell Anatomy 0.000 claims description 5
- 239000002356 single layer Substances 0.000 claims description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- 238000009825 accumulation Methods 0.000 claims description 3
- 210000005260 human cell Anatomy 0.000 claims description 3
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000002609 medium Substances 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 238000004114 suspension culture Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 238000004113 cell culture Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 241000991587 Enterovirus C Species 0.000 description 7
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 241000709701 Human poliovirus 1 Species 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- 229920002873 Polyethylenimine Polymers 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000007997 Tricine buffer Substances 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 3
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
- XSNSOQNHJHPRQG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-(chloromethyl)oxirane Chemical compound ClCC1CO1.OCCN(CCO)CCO XSNSOQNHJHPRQG-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000941423 Grom virus Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 101100388690 Plasmodium falciparum (isolate K1 / Thailand) MEF-1 gene Proteins 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229940124867 Poliovirus vaccine Drugs 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000009828 non-uniform distribution Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000013376 serial cultivation Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/78—Cellulose
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B61/00—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing
- F02B61/04—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing for driving propellers
- F02B61/045—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing for driving propellers for marine engines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8402742A SE454518B (sv) | 1984-05-21 | 1984-05-21 | Forfarande for odling av diploida celler i nervaro av cellulosafibrer |
| JP60502558A JPS62500001A (ja) | 1984-05-21 | 1985-05-21 | 細胞増殖 |
| EP85902710A EP0216771A1 (en) | 1984-05-21 | 1985-05-21 | Methods for culturing diploid cells on cellulose fibers |
| PCT/SE1985/000213 WO1985005375A1 (en) | 1984-05-21 | 1985-05-21 | Methods for culturing diploid cells on cellulose fibers |
| DK19086A DK19086A (da) | 1984-05-21 | 1986-01-15 | Fremgangsmaade til dyrkning af diploidceller paa cellulosefibre |
| NO860180A NO860180L (cs) | 1984-05-21 | 1986-01-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8402742A SE454518B (sv) | 1984-05-21 | 1984-05-21 | Forfarande for odling av diploida celler i nervaro av cellulosafibrer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8402742D0 SE8402742D0 (sv) | 1984-05-21 |
| SE8402742L SE8402742L (sv) | 1985-11-22 |
| SE454518B true SE454518B (sv) | 1988-05-09 |
Family
ID=20355970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8402742A SE454518B (sv) | 1984-05-21 | 1984-05-21 | Forfarande for odling av diploida celler i nervaro av cellulosafibrer |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0216771A1 (cs) |
| JP (1) | JPS62500001A (cs) |
| DK (1) | DK19086A (cs) |
| NO (1) | NO860180L (cs) |
| SE (1) | SE454518B (cs) |
| WO (1) | WO1985005375A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3402927A1 (de) * | 1984-01-28 | 1985-08-08 | Pfeifer & Langen, 5000 Köln | Zellkulturmikrotraeger, verfahren zu seiner herstellung und seine verwendung zum zuechten von verankerungsabhaengigen zellen |
| US4874810A (en) * | 1986-03-07 | 1989-10-17 | General Electric Company | Impact modified polyphenylene ether-polyamide compositions |
| US8539900B2 (en) | 2009-12-30 | 2013-09-24 | Alex R. Kaye and Frances Kaye Trust | Folding transom for a collapsible boat |
| US9278730B2 (en) | 2009-12-30 | 2016-03-08 | Alex R. Kaye and Frances Kaye Trust | Brace for folding transom |
| JP5846550B2 (ja) * | 2011-05-02 | 2016-01-20 | 国立研究開発法人物質・材料研究機構 | 短繊維足場材料、短繊維−細胞複合凝集塊作製方法及び短繊維−細胞複合凝集塊 |
| TW201738256A (zh) * | 2016-04-04 | 2017-11-01 | 日產化學工業股份有限公司 | 蛋白質產生方法 |
| JP6799316B2 (ja) * | 2016-09-12 | 2020-12-16 | 国立研究開発法人物質・材料研究機構 | 配向性を有する短繊維−細胞複合凝集塊を製造するための方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA776251B (en) * | 1976-11-11 | 1978-07-26 | Massachusetts Inst Technology | Improved cell culture microcarriers |
| FR2396083A1 (fr) * | 1977-06-30 | 1979-01-26 | Merieux Inst | Procede de culture de virus |
| US4352887A (en) * | 1979-10-29 | 1982-10-05 | Albert Einstein College Of Medicine Of Yeshiva University | Method and article for culturing differentiated cells |
| JPS59164723A (ja) * | 1983-03-10 | 1984-09-17 | Koken:Kk | 再生コラーゲンフイブリルを含有する基質及びその製造方法 |
-
1984
- 1984-05-21 SE SE8402742A patent/SE454518B/sv not_active IP Right Cessation
-
1985
- 1985-05-21 JP JP60502558A patent/JPS62500001A/ja active Pending
- 1985-05-21 EP EP85902710A patent/EP0216771A1/en not_active Withdrawn
- 1985-05-21 WO PCT/SE1985/000213 patent/WO1985005375A1/en not_active Application Discontinuation
-
1986
- 1986-01-15 DK DK19086A patent/DK19086A/da not_active Application Discontinuation
- 1986-01-20 NO NO860180A patent/NO860180L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE8402742L (sv) | 1985-11-22 |
| JPS62500001A (ja) | 1987-01-08 |
| SE8402742D0 (sv) | 1984-05-21 |
| EP0216771A1 (en) | 1987-04-08 |
| NO860180L (cs) | 1986-01-20 |
| WO1985005375A1 (en) | 1985-12-05 |
| DK19086A (da) | 1986-03-03 |
| DK19086D0 (da) | 1986-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008207588B2 (en) | Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture | |
| AU2002338666B2 (en) | Multiplication of viruses in a cell culture | |
| JP2006320328A (ja) | ウィルス増殖のための不死化細胞系 | |
| Wong et al. | Changing viral susceptibility of a human cell line in continuous cultivation: I. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or N-WS influenza viruses | |
| HRP950097A2 (en) | Hepatitis a virus culture process | |
| Berry et al. | Production of reovirus type‐1 and type‐3 from Vero cells grown on solid and macroporous microcarriers | |
| CN101094915A (zh) | 生产流感疫苗的方法 | |
| EP1497468A1 (en) | Cells for detection of influenza and parainfluenza viruses | |
| SE454518B (sv) | Forfarande for odling av diploida celler i nervaro av cellulosafibrer | |
| Danner et al. | In vitro studies on Borna virus: I. The use of cell cultures for the demonstration, titration and production of Borna virus | |
| Ahamed et al. | Adaptation of Newcastle disease virus (NDV) on Vero cell line | |
| CN102127524A (zh) | 细胞载体生物反应器大量繁殖禽流感病毒的方法 | |
| US3935066A (en) | Cell lines | |
| RU2722671C1 (ru) | BHK-21/SUSP/ARRIAH - перевиваемая суспензионная сублиния клеток почки новорожденного сирийского хомячка, предназначенная для репродукции вирусов ящура, бешенства, парагриппа-3, болезни Ауески при производстве противовирусных вакцин, а также для изготовления диагностических и профилактических ветеринарных биопрепаратов | |
| CN108779438A (zh) | Mdck细胞的培养方法 | |
| SK279236B6 (sk) | Bezsérové bunkové kultúry na výrobu antigénov a sp | |
| Yoshimura et al. | In vitro differentiation of chicken embryo skin cells transformed by Rous sarcoma virus | |
| Arnheiter | Primary monolayer culture of adult mouse hepatocytes—A model for the study of hepatotropic viruses | |
| Varani et al. | Human diploid fibroblast growth on polystyrene microcarriers in aggregates | |
| RU2496870C2 (ru) | Способ получения эпителиоподобных клеток легкого плода буйволицы для культивирования вирусов | |
| Kusano et al. | General characteristics of the cells transformed in vitro by human adenovirus type 12 | |
| JP2011205968A (ja) | 細胞培養によるインフルエンザワクチンの製造方法 | |
| RU2076905C1 (ru) | Способ суспензионного культивирования филовирусов в клеточных культурах на микроносителях | |
| CN1995333A (zh) | 静宁鸡胚成纤维细胞系及其培养方法 | |
| CN101012451A (zh) | 蒙古马耳缘组织成纤维细胞系及其培养方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8402742-4 Effective date: 19900518 Format of ref document f/p: F |